Genistein-induced mir-23b expression inhibits the growth of breast cancer cells

Autor: Avci CB, Susluer SY, Caglar HO, Balci T, Aygunes D, Dodurga Y, Gunduz C

AIM OF THE STUDY: Genistein, an isoflavonoid, plays roles in the inhibition of protein tyrosine kinase phosphorylation, induction of apoptosis, and cell differentiation in breast cancer. This study aims to induce cellular stress by exposing genistein

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::18398caf84f374e18ebd4830260a7747

acid treatment in neuroblastoma cells

Autor: Avci, CB, Dodurga, Y, Gundogdu, G, Caglar, HO, Kucukatay, V, Gunduz, C, Satiroglu-Tufan, NL

Neuroblastoma (NB), originating from neural crest cells, is the most common extracranial tumor of childhood. Retinoic acid (RA) which is the biological active form of vitamin A regulates differentiation of NB cells, and RA derivatives have been used

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::26a1bed545f01d1d2fd85280dffc6081
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/14090

Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris.

Autor: Kalyoncu S; Izmir Biomedicine and Genome Center, Izmir, Turkey., Yilmaz S; Izmir Biomedicine and Genome Center, Izmir, Turkey.; VIB-UGent Center for Medical Biotechnology, Gent, Belgium., Kuyucu AZ; Izmir Biomedicine and Genome Center, Izmir, Turkey., Sayili D; Izmir Biomedicine and Genome Center, Izmir, Turkey., Mert O; Izmir Biomedicine and Genome Center, Izmir, Turkey., Soyturk H; Izmir Biomedicine and Genome Center, Izmir, Turkey., Gullu S; Izmir Biomedicine and Genome Center, Izmir, Turkey., Akinturk H; Izmir Biomedicine and Genome Center, Izmir, Turkey., Citak E; Izmir Biomedicine and Genome Center, Izmir, Turkey.; VIB-UGent Center for Medical Biotechnology, Gent, Belgium., Arslan M; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey., Taskinarda MG; Izmir Biomedicine and Genome Center, Izmir, Turkey., Tarman IO; Izmir Biomedicine and Genome Center, Izmir, Turkey., Altun GY; Izmir Biomedicine and Genome Center, Izmir, Turkey., Ozer C; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey., Orkut R; Izmir Biomedicine and Genome Center, Izmir, Turkey., Demirtas A; Izmir Biomedicine and Genome Center, Izmir, Turkey., Tilmensagir I; Izmir Biomedicine and Genome Center, Izmir, Turkey., Keles U; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Lund University, Lund, Sweden., Ulker C; Izmir Biomedicine and Genome Center, Izmir, Turkey., Aralan G; Izmir Biomedicine and Genome Center, Izmir, Turkey., Mercan Y; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey., Ozkan M; Izmir Biomedicine and Genome Center, Izmir, Turkey., Caglar HO; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Erzurum Technical University, Erzurum, Turkey., Arik G; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Ankara Medipol University, Ankara, Turkey., Ucar MC; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Imperial College London, London, UK., Yildirim M; Izmir Biomedicine and Genome Center, Izmir, Turkey., Yildirim TC; Izmir Biomedicine and Genome Center, Izmir, Turkey., Karadag D; Izmir Biomedicine and Genome Center, Izmir, Turkey., Bal E; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir Tinaztepe University, Izmir, Turkey., Erdogan A; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey., Senturk S; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey., Uzar S; Pendik Veterinary Research and Control Institute, Istanbul, Turkey., Enul H; Pendik Veterinary Research and Control Institute, Istanbul, Turkey., Adiay C; Pendik Veterinary Research and Control Institute, Istanbul, Turkey., Sarac F; Pendik Veterinary Research and Control Institute, Istanbul, Turkey., Ekiz AT; Marmara Research Center, TUBITAK, Kocaeli, Turkey., Abaci I; Marmara Research Center, TUBITAK, Kocaeli, Turkey., Aksoy O; Marmara Research Center, TUBITAK, Kocaeli, Turkey., Polat HU; Marmara Research Center, TUBITAK, Kocaeli, Turkey., Tekin S; Marmara Research Center, TUBITAK, Kocaeli, Turkey.; University of Health Sciences, Istanbul, Turkey., Dimitrov S; Izmir Biomedicine and Genome Center, Izmir, Turkey., Ozkul A; Ankara University, Ankara, Turkey., Wingender G; Izmir Biomedicine and Genome Center, Izmir, Turkey., Gursel I; Izmir Biomedicine and Genome Center, Izmir, Turkey., Ozturk M; Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir Tinaztepe University, Izmir, Turkey., Inan M; Izmir Biomedicine and Genome Center, Izmir, Turkey. mehmet.inan@ibg.edu.tr.; Akdeniz University, Antalya, Turkey. mehmet.inan@ibg.edu.tr.

Publikováno v: Scientific reports [Sci Rep] 2023 Mar 30; Vol. 13 (1), pp. 5224. Date of Electronic Publication: 2023 Mar 30.

AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.

Autor: Aytatli A; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey., Barlak N; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey., Sanli F; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey., Caglar HO; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey., Gundogdu B; Department of Medical Pathology, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Tatar A; Department of Otorhinolaryngology Diseases, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Ittmann M; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, 77030, USA.; Michael E. DeBakey VAMC, Houston, TX, 77030, USA., Karatas OF; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey. faruk.karatas@erzurum.edu.tr.; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey. faruk.karatas@erzurum.edu.tr.

Publikováno v: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2022 Feb; Vol. 45 (1), pp. 41-56. Date of Electronic Publication: 2021 Nov 27.

Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs.

Autor: Cesmeli S; Department of Medical Biology, Medical Faculty, Ege University, 35100, Izmir, Turkey., Goker Bagca B; Department of Medical Biology, Medical Faculty, Aydın Adnan Menderes University, 09010, Aydın, Turkey., Caglar HO; Department of Molecular Biology and Genetics, Science Faculty, Erzurum Technical University, 25250, Erzurum, Turkey., Ozates NP; Department of Medical Biology, Medical Faculty, Ege University, 35100, Izmir, Turkey., Gunduz C; Department of Medical Biology, Medical Faculty, Ege University, 35100, Izmir, Turkey., Biray Avci C; Department of Medical Biology, Medical Faculty, Ege University, 35100, Izmir, Turkey. cbavci@gmail.com.

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2021 Nov 15; Vol. 39 (1), pp. 12. Date of Electronic Publication: 2021 Nov 15.